Vous avez cherché: glukosurja (Maltais - Anglais)

Żamma tal-awrina, glukosurja
urinary retention, glycosuria

Żamma ta’ l-awrina, glukosurja
urinary retention, glycosuria

riżultati negattivi foloż jistgħu jinkisbu meta jintużaw metodi ta’ glucose-oxidase għal glukosurja.
false negative results might be obtained upon application of glucose-oxidase methods for glucosuria.

kolesterol2, 3 livelli g olja ta 'glucose4 livelli g olja ta' trigli eridi2, 5 glukosurja ieda fl- aptit
elevated cholesterol levels2,3 elevated glucose levels4 elevated triglyceride levels2,5 glucosuria increased appetite

huwa rakkomandabbli li ma jinqabiżx id- dożaġġ rakkomandat minħabba r- riskji potenzjali ta 'akromegalija, ipergliċemija, u glukosurja.
it is advisable not to exceed the recommended dosage in view of the potential risks of acromegaly, hyperglycaemia, and glucosuria.

eridi (ara sezzjoni 4. 4), glukosurja, ż fl- aptit, għ ta 'prolactin, kolesterol, glucose u trigliċ
adults the most frequently (seen in ≥ 1% of patients) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appet ite, dizziness, akathisia, parkinsonism (see section 4.4), dyskinesia, orthostatic hypotension, anticholinergic effects, transient asymptomatic elevations of hepatic transaminases (see section 4.4), rash, asthenia, fatigue and oedema.

fi studji kliniċi, l-aktar reazzjonijiet avversi li ġew irrapportati b'mod frekwenti (jidhru f'> 1% tal- pazjenti) u li huma assoċjati ma' l-użu ta' l-olanzapine kienu sonnolenza, żieda fil-piż, eosinofilja, livelli għolja ta' prolactin, kolesterol, glucose u trigliċeridi (ara taqsima 4.4), glukosurja, żieda fl- aptit, sturdament, akatiżja, parkinsoniżmu, lewkopenija, newtropenija (ara taqsima 4.4), diskineżja, pressjoni baxxa mal-waqfien, effetti antikolinerġiċi, żieda fil-livelli tal- aminotransferases tal-fwied li ma jurux sintomi u li huma momentanji (ara taqsima 4.4), raxx, astenja, għeja, deni, artralġja, żieda fil-livell tal-alkaline phophatase, livell għoli ta’ gamma glutamyltransferase, livell għoli ta’ aċtu uriku, livell għoli ta’ creatine phosphokinase u edima.
the most frequently (seen in ≥ 1% of patients ) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appetite, dizziness, akathisia, parkinsonism, leukopenia, neutropenia (see section 4.4), dyskinesia, orthostatic hypotension, anticholinergic effects, transient asymptomatic elevations of hepatic aminotransferases (see section 4.4), rash, asthenia, fatigue, pyrexia, arthralgia, increased alkaline phosphatase, high gamma glutamyltransferase, high uric acid, high creatine phosphokinase and oedema.